Vaccines R&D-2017
United Scientific Group (USG) successfully completed First International Conference on Vaccines Research and Development, in Baltimore, MD, USA during November 02-04, 2015 (Vaccines R&D-2015) and Second International Conference on Vaccines Research and Development in Cartagena, Colombia during and November 10-12, 2016 (Vaccines R&D-2016).
With the enthusiasm and prodigious success of two annual conferences, USG are proudly announcing the Third International Conference on Vaccines Research and Development at Washington D.C, USA during November 13-15, 2017 (Vaccines R&D-2017).
The organizing committee is confident that participants will benefit from the high value scientific program and welcome all the researchers and experts to join us for these 3 days of stimulating discussions, knowledge sharing and networking event.
Speaker and Presenter Information
Jay A Berzofsky
Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute, USA
Stephen L. Hoffman
Chief Executive and Scientific Officer, Sanaria Inc., USA
Manuel Elkin Patarroyo M
Director, Fundacion Instituto de Inmunologia de Colombia
Odile Leroy
Executive Director, European Vaccine Initiative, Germany
Pierre A. MORGON
Chief Executive Officer, MRGN Advisors, Switzerland
Suresh Jadhav
Executive Director, Serum Institute of India Pvt. Ltd, India
Michael G. Hanna
Founder and Chief Executive Officer, Vaccinogen, Inc., USA
Marc Van Regenmortel
University of Strasbourg, France
Expected Number of Attendees
350
This event has no exhibitor/sponsor opportunities
When
Mon-Wed, Nov 13-15, 2017, 9:00am - 6:00pm
Cost
| Early Bird Registration: | $349.00 |
Where
Sheraton Reston Hotel
11810 Sunrise Valley Dr
Reston, VA 20191
Get directions
Website
Click here to visit event website
Organizer
United Scientific Group
